Fresenius SE & Co KGaA/ DE0005785604 /

8/11/2022 4:53:14 PM	Chg. -0.01	Volume	Bid5:30:00 PM	Ask5:30:00 PM	Market Capitalization	Dividend Y.	P/E Ratio
24.75EUR	-0.02%	920 Turnover: 22,763.12	-Bid Size: -	-Ask Size: -	13.83 bill.EUR	3.72%	7.60

GlobeNewswire 6/11/2021 UPDATE -- Humacyte Expands Strategic Global Partnership with Fresenius Medical Care

GlobeNewswire 6/11/2021 Humacyte Expands Strategic Global Partnership with Fresenius Medical Care

GlobeNewswire 2/4/2021 Cove Capital Acquires Fresenius Medical Care Dialysis Facility in New Orleans

GlobeNewswire 11/11/2019 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medica...

GlobeNewswire 11/7/2019 eGenesis Announces $100 Million Series B Financing

GlobeNewswire 11/4/2019 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medica...

GlobeNewswire 10/29/2019 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Fresenius Medica...

GlobeNewswire 10/23/2019 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medic...

GlobeNewswire 2/20/2019 Akorn Comments on Fresenius’ Proposed Amended Claims

GlobeNewswire 10/18/2018 Akorn Appeals Fresenius Kabi Ruling

GlobeNewswire 7/16/2018 OPKO Partner Vifor Fresenius Receives Marketing Approval for RAYALDEE in Canada

GlobeNewswire 2/21/2018 Global Kidney Dialysis Equipment and Supplies Markets 2016-2024: Fresenius and Baxter Dominate the M...

TeleTrader 8/7/2017 Fresenius Medical buys NxStage for $2 billion

GlobeNewswire 7/19/2017 Akorn Shareholders Vote to Approve Merger Agreement with Fresenius Kabi

GlobeNewswire 6/9/2017 KISSEI TO MARKET AVACOPAN IN JAPAN FOR VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA

GlobeNewswire 4/7/2017 Akorn Confirms Discussions with Fresenius Kabi

GlobeNewswire 1/27/2011 Swedish Orphan Biovitrum agrees with Fresenius Biotech to distribute Removab®